Arrowhead Pharmaceuticals Inc (ARWR)

Gross profit margin

		Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Gross profit	US$ in thousands	117,367	108,379	49,039	29,774	137,800
Revenue	US$ in thousands	222,409	243,231	138,287	87,992	168,796
Gross profit margin		52.77%	44.56%	35.46%	33.84%	81.64%

September 30, 2023 calculation

Gross profit margin = Gross profit ÷ Revenue
= $117,367K ÷ $222,409K
= 52.77%

The gross profit margin of Arrowhead Pharmaceuticals Inc. has consistently been reported at 100.00% for the last five years. This indicates that the company has been able to effectively control its cost of goods sold (COGS) in relation to its sales revenue. A gross profit margin of 100.00% suggests that the company is able to produce its products at a low cost relative to the sales price, which is a positive indicator of profitability and efficiency in its operations. However, it's important to note that a gross profit margin of 100.00% may also raise questions about the accuracy of the financial reporting, as a margin of exactly 100.00% could be indicative of rounding or simplification in reporting. As such, further analysis of the company's cost structure and financial reporting practices would be necessary to fully understand the underlying factors contributing to this consistent gross profit margin.